Preformulation-Assisted Design of Ketorolac Tromethamine for Effective Ophthalmic Delivery

J Ocul Pharmacol Ther. 2023 Dec;39(10):725-734. doi: 10.1089/jop.2023.0066. Epub 2023 Sep 7.

Abstract

Background: The eye is a highly protected organ from ocularly administered drugs; drug- and formulation-related factors contribute significantly to ocular bioavailability. There has been a growing interest in using nonsteroidal anti-inflammatory drugs in ophthalmology for treating postoperative pain, inflammation, and seasonal allergic conjunctivitis. A preformulation-assisted design boosts efficacy and reduces dose requirements. Methods: This work aims to study the preformulation characteristics of ketorolac tromethamine to improve ocular performance and future formulation development through developing an high-performance liquid chromatography (HPLC) stability-indicating assay, forced degradation under stress conditions, solubility, as well as partition and distribution coefficient measurements. An isocratic HPLC with diode array detector method was developed and validated. Accelerated degradation under different stressors (acid, alkali, heat, and oxidative) was studied. In addition, solubility, partition, and distribution were investigated at different pHs of 3.5-7.4. Results: The results indicated that the developed HPLC method was simple, rapid (retention time ≃3 min), sensitive, selective, robust, and stability indicating. The drug seems more chemically sensitive to acid degradation (∼30% and 40% of the drug was degraded under 0.1 M and 1 M HCl at 60°C for 24 h, respectively). Another significant degradation was recorded in the following order: Oxidative > alkali > heat (phosphate-buffered saline) > heat (distilled water). Being a weak ionizable drug, both water and lipid solubility, as measured through partition coefficients, it demonstrated pH-dependency. Conclusion: For the optimum balance of water and lipid solubility required for penetration through the lipophilic corneal epithelial barrier, ketorolac eye drops would be better formulated between pH 5.5 and 6.6 than being formulated at the physiological fluid pH 7.4, where the drug is extremely hydrophilic and less permeable.

Keywords: ketorolac; lipophilicity; partition coefficient; preformulation; solubility; validation.

MeSH terms

  • Alkalies
  • Anti-Inflammatory Agents, Non-Steroidal* / therapeutic use
  • Ketorolac
  • Ketorolac Tromethamine*
  • Lipids
  • Ophthalmic Solutions
  • Water

Substances

  • Ketorolac Tromethamine
  • Anti-Inflammatory Agents, Non-Steroidal
  • Ketorolac
  • Alkalies
  • Water
  • Lipids
  • Ophthalmic Solutions